How Manual Tools Fall Short for Regulatory Affairs Processes
Blog: BP Logix Blog
Efficient processes are critical for regulatory affairs teams aiming to bring new drugs to market. However, many organizations still depend on manual, decentralized tools like Excel and Outlook to navigate highly regulated and complex processes. While these tools may appear cost-effective and familiar, they pose practical challenges when applied to Investigational New Drug (IND) and New Drug Application (NDA) processes. These challenges can ultimately impede progress and lead to delays or regulatory consequences.
Leave a Comment
You must be logged in to post a comment.
